1. Home
  2. TCON

TCON

TRACON Pharmaceuticals Inc.

Logo TRACON Pharmaceuticals Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-17-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
-
.
-
-
%

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.

Founded: 2004 Country:
United States
United States
Employees: N/A City: San Diego
Market Cap: 5.4M IPO Year: 2015
Target Price: $60.00 AVG Volume (30 days): 195.6K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.20 EPS Growth: N/A
52 Week Low/High: $2.25 - $42.40 Next Earning Date: 05-08-2024
Revenue: $12,045,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: